Knowledge, Attitude, Practice and Barriers on Vaccination against Human Papillomavirus Infection: A Cross-Sectional Study among Primary Care Physicians in Hong Kong

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wong, Martin C S ^a   Lee, Albert ^a   Ngai, Karry L K ^a   Chor, Josette C Y ^a   Chan, Paul K S ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG UPTAKE; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HONG KONG; HUMAN; KNOWLEDGE; MALE; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PHYSICIAN ATTITUDE; PREVALENCE; PROFESSIONAL COMPETENCE; QUESTIONNAIRE; SCHOOL CHILD; SEXUAL BEHAVIOR; SOCIAL STATUS;

CHLAMYDIA; HERPES; HUMAN PAPILLOMAVIRUS;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HONG KONG; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIANS, PRIMARY CARE; PREVALENCE; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84882714029     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071827     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention. Available: http://www.cdc.gov/hpv/. Accessed: 2010 May.
2. Chan PKS, Ho WCS, Wong MC, Chang AR, Chor JSY, et al. (2009) Epidemiologic risk profile of infection with different groups of human papillomaviruses. J MedVirol 81: 1635-44.
3. Schiffman M, Castle PE, (2003) Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 127: 930-4.
4. Trottier H, Franco EL, (2005) The epidemiology of genital human papillomavirus infection. Vaccine 24: S1-15.
5. Franco E, Harper DM, (2005) Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 23: 2388-94.
6. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med 348: 518-27.
7. Garland S, Park S, Ngan H, Frazer I, Tay EH, et al. (2008) The need for public education on HPV and cervical cancer prevention in Asia: Opinions of experts at the AOGIN Conference. Vaccine 26: 5435-40.
8. Lee A, Chan PKS (2012) Interim result for school based cervical cancer education and prevention programme. 50th Anniversary Multidisciplinary Conference, The Hong Kong Paediatric Society. Hong Kong, 17-19 Aug 2012.
9. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, et al. (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6: 271-8.
10. Villa LL, Costa RL, Petta CA, Andrade RP, Paavonen J, et al. (2006) High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 95: 1459-66.
11. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, et al. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364: 1757-65.
12. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, et al. (2006) Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367: 1247-55.
13. Saslow D, Boetes C, Burke W, Harms S, Leach MO, et al. (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57: 75-89. Erratum in: CA Cancer J Clin 2007 57(3): 185.
14. Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, et al. (2004) Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 96: 604-15.
15. Adams M, Jasani B, Fiander A, (2007) Human papillomavirus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine 25: 3007-13.
16. Zimet GD, Mays RM, Fortenberry JD, (2000) Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm Dis 27: 49-52.
17. Riedesel JM, Rosenthal SL, Zimet GD, Bernstein DI, Huang B, et al. (2005) Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 18: 391-8.
18. Dinh TA, Rosenthal SL, Doan ED, Trang T, Pham VH, et al. (2007) Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Health 40: 559-63.
19. Gerend MA, Lee SC, Shepherd JE, (2007) Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis 34: 468-71.
20. Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, et al. (2007) Parental intention to have daughters receive the human papillomavirus vaccine. CMAJ 177(12): 1506-12.
21. Daley MF, Liddon N, Crane LA, Beaty BL, Barrow J, et al. (2006) A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics 118: 2280-9.
22. Jaspan DM, Dunton CJ, Cook TL (2008) Acceptance of human papillomavirus vaccine by Gynecologists in an urban setting. J Low Genital Tract Dis 12: 11 8-21.
23. Dixon E (2011) An assessment of HPV vaccination by Georgia physicians: knowledge, barriers, supports, practices, and adherence to ACIP guidelines and recommendations. A Dissertation Submitted to the Graduate Faculty of Georgia Southern University in Partial Fulfillment of the Requirements for the Degree Doctor of Public Health, Statesboro, Georgia, 2011.
24. Raley JC, Followwill KA, Zimet GD, Ault KA, (2004) Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 12: 127-33.
25. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, et al. (2010) Human Papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 126: 425-33.
26. Huey NL, Clark AD, Kluhsman BC, Lengerich EJ, (2009) the ACTION Health Cancer Task Force (2009) HPV vaccine attitudes and practices among primary care providers in Appalachian Pennsylvania. Prev Chronic Dis 6: A49.
27. Tan J, Farrell L, Allen DG, (2010) The attitudes of Australian gynaecologists to HPV vaccination: An ASCCP survey. Aust N Z J Obstet Gynaecol 50: 472-7.
28. Hopkins TG, Wood NJ, West RM, Darling JC, (2009) UK health professionals' attitudes and knowledge regarding Human Papillomavirus (HPV) vaccination: A West Yorkshire Study. J Paediatr Child Health 45: 652-5.
29. Duval B, Gilca V, McNeil S, Dobson S, Money D, et al. (2007) Vaccination against human papillomavirus: A baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 25: 7841-7.
30. Chan PKS, Picconi MA, Cheung TH, Giovannelli L, Park JS, (2012) Laboratory and clinical aspects of human papillomavirus testing. Crit Rev Clin Lab Sci 49: 117-36.
31. Chan ZC, Chan TS, Lam YM, Lau LM, Li KK, et al. (2011) HPV vaccination in Hong Kong: implications for medical education. Asian Pac J Cancer Prev 12: 1095-9.
32. Chan PKS, Cheung TH, Li WH, Yu MY, Chan MYM, et al. (2012) Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in southern China. Int J Cancer 131: 692-705.
33. Franco MFE (2011) Physicians' attitudes towards human papillomavirus vaccination programme: a systematic review. Dissertation submitted to the University of Chester for the Degree of Master of Science (Public Health) in partial fulfilment of the Modular Programme in Public Health, 2011.
34. US Food and Drug Administration (2006) FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. Available: www.fda.gov/bbs/topics/NEWS/2006/NEW01385.html. Accessed 2012 Sep.
35. Centers for Disease Control and Prevention (2012) CDC's Advisory Committee recommends human papillomavirus virus vaccination. Available: www.cdc.gov/od/oc/media/pressrel/r060629.htm. Accessed 2012 Sep.